%D8%AD%D9%85%D8%B6_%D8%A7%D9%84%D9%83%D9%84%D8%A7%D9%81%D9%88%D9%84%D9%8A%D9%86%D9%8A%D9%83%C3%80cid_clavul%C3%A0nicCategory:Clavulanic_acidClavulans%C3%A4ureClavulanic_acid%C3%81cido_clavul%C3%A1nico%DA%A9%D9%84%D8%A7%D9%88%D9%88%D9%84%D8%A7%D9%86%DB%8C%DA%A9_%D8%A7%D8%B3%DB%8C%D8%AFKlavulaanihappoAcide_clavulaniqueKlavul%C3%A1nsavAcido_clavulanico%E3%82%AF%E3%83%A9%E3%83%96%E3%83%A9%E3%83%B3%E9%85%B8%ED%81%B4%EB%9D%BC%EB%B6%88%EB%9E%80%EC%82%B0%D0%9A%D0%BB%D0%B0%D0%B2%D1%83%D0%BB%D0%B0%D0%BD%D1%81%D0%BA%D0%B0_%D0%BA%D0%B8%D1%81%D0%B5%D0%BB%D0%B8%D0%BD%D0%B0ClavulaanzuurKwas_klawulanowy%C3%81cido_clavul%C3%A2nicoAcid_clavulanic%D0%9A%D0%BB%D0%B0%D0%B2%D1%83%D0%BB%D0%B0%D0%BD%D0%BE%D0%B2%D0%B0%D1%8F_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0Klavulanska_kiselinaKlavulanska_kislinaKlavulanska_kiselinaKlavulansyra%D0%9A%D0%BB%D0%B0%D0%B2%D1%83%D0%BB%D0%B0%D0%BD%D0%BE%D0%B2%D0%B0_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0Q415709%E5%85%8B%E6%8B%89%E7%B6%AD%E9%85%B8
about
sameAs
A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis MediaComparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial SinusitisA Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear InfectionsEffectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary DiseaseStudy to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial RhinosinusitisSystemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in ChildrenThe Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaStudy Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin InfectionsZmax Compared to Augmentin in SinusitisNon Operative Treatment for Acute AppendicitisMoxifloxacin in Pediatric Subjects With Complicated Intra-abdominal InfectionEffects of S. Boulardii and Amoxicillin/Clavulanate on Gut MicrobiotaEfficacy of Short-Course Antimicrobial Treatment for Children With Acute Otitis Media and Impact on ResistanceExamination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract InfectionsShort Duration Treatment of Non-severe Community Acquired PneumoniaCulture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter PyloriComparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic UseEarly-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic TreatmentSafety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical ProceduresA Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ ClavulanateBioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers UComparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in AdultsTreatment of Acute Sinusitis With High-Dose vs. Standard-Dose Amoxicillin/ClavulanateTrial on the Ideal Duration of Oral Antibiotics in Children With PneumoniaMechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics (R61)Antibiotic Dosing in Patients on Intermittent HemodialysisThe Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without PolypAntibiotic Duration in Post-appendectomy AbscessBioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting ConditionsThe Effects of Clavulanic Acid on Tobacco Use Disorder2-day Prophylactic Antibiotic is Effective in Transoral Endoscopic ThyroidectomyBacteriological Study of Acute Follicular TonsillitisAzithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive UnitEffect of Tebipenem on Normal Human Intestinal MicrobiotaHigher Versus Standard Dose of Amoxicillin-clavulanate in Pediatric PBBPharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural InfectionsShort Therapy for Febrile UTI in Childhood
P4844
Is the standard dose of amoxicillin-clavulanic acid sufficient?Clavulanic acid, a beta-lactamase inhibitor: biosynthesis and molecular genetics.New reactions in clavulanic acid biosynthesis.Screening of wild type Streptomyces isolates able to overproduce clavulanic acid.Oral amoxicillin-clavulanic Acid treatment in urinary tract infections caused by extended-spectrum Beta-lactamase-producing organisms.Clavulanic acid: a review.The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.beta-Lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies.Clavulanic acid: a competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects.Effects of Amoxicillin and Clavulanic Acid on the Spontaneous Mechanical Activity of Juvenile Rat Duodenum.Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
P921
Q61914478-4632807D-4D40-4C2D-A59C-530C46829FE2Q61914521-73D24CBF-0A2D-43F9-BE7E-F1207EC04A2AQ61914639-205BF36B-554E-4105-BBA8-5319AE4F05C2Q61917555-1520F80F-18AE-4757-8F0A-3C7FC2EA1BCAQ61917838-57597562-C66E-4AEA-ABDA-334B22536CC3Q61920559-60D13AB4-F3CA-4D23-8D9F-EADF73BA77F6Q61921709-7F24DE3D-79FB-44A3-B296-8403912722B2Q61924593-0B472F6A-A5BC-4286-9C67-680E12EAE2DEQ61933700-2B61DA44-C61F-467A-BC69-0A697895F3BFQ61933967-80E491E3-7056-4F00-9555-2734C776E69EQ61936495-61229075-B5E2-4E4C-9571-DE6C89588E54Q61938872-7EC0CB10-BB7A-4AAD-883E-0C28A2A8CABDQ61955354-AEBBB791-CF78-4F1D-A06D-F6935D0D7B5DQ61956081-DDE2ACD9-F42A-47BF-BB78-AB197FA16A9DQ61956654-C35B479B-C5A6-4909-B5D2-0C67834D084DQ61975924-68FDFF46-FC12-4A5F-A1B3-2790D5CCD412Q63013213-0313F188-6C05-49A2-B33E-CCF80BB1C38DQ63315742-AF8041A1-77FA-4E73-882C-4E842DEE3A46Q63316340-0ED3C55D-696D-45CE-97CA-3AC04C89C395Q63316905-3C99D6F1-DF9F-4BF0-9487-1F1587820007Q63316963-9E436398-7522-44E9-B4B5-B7AA01FDB470Q63319362-D8BB2C0D-9B84-49AA-A181-B11B0DD1B5DCQ63320452-C1DD0AD2-136A-439A-908D-9784C032AE58Q63393978-3ECBB1FC-59B4-4192-9CF3-73A1CA37724AQ63401916-BE7706ED-154A-4AF9-B137-58B1E851AA39Q63404025-33D59A9E-C270-46F5-B44E-E491A7F31C5AQ63571427-DB67DCE4-991F-496E-ACAD-4B40DF992C59Q63575480-C2C8D519-552D-41E8-94C3-156404338A7BQ63579844-43453159-6D41-4C6B-AC52-534714ACE94DQ63583852-BEFCA9C1-D2B0-40D5-81DE-B6E140DF3C15Q63593183-1F944DED-AF62-4609-B55F-17425FFE2781Q63596564-B273EFE9-68C1-40D6-9D3D-5A9806BED1E6Q63599043-8895FA05-2A23-4C05-8D3C-DD30361AD9A5Q86291241-964D6E2B-9F32-4371-AF18-BDDE1FEEAF09Q89154712-11D6BE3B-C61A-4A58-8251-87EE0AEF8428Q92272124-BC8FD3A2-54B8-4528-839F-4B88062D9357Q93475843-D2E775CC-178C-43D2-AF5E-07ABAA7B86C1Q93581391-25732483-01B8-45BB-82BC-75E71E92C4A2Q93704577-8215967A-DBE8-4647-AFF7-482CA2EBAD3DQ95172162-93B5FB5B-427B-43A8-906E-16CDBCF42FE8
P4844
Q34030839-E8ECA3EC-8687-41BF-A225-11CCBED914D6Q34090602-A78B0E65-6809-4E07-9E1E-76BFE33185AFQ34157428-22B1998F-9F74-4650-814D-A158340DCF5AQ34380126-6BC8409A-18B2-4231-B772-866C5D37706AQ35132012-3293D083-B0E7-41D1-A297-0858AD497232Q37152276-150F7E6B-A2F8-437B-920D-60704A45E635Q37330476-457E53F3-9787-4699-9794-F5DA80E66B8DQ42549858-EC6419DB-C3C6-46E3-B5E5-0AB40B362F02Q46036916-0F6B1928-A1BE-40A0-8302-B8C2764757C4Q48505685-01AE78AC-42CD-4DFA-B1E5-CA72008C9755Q53497512-FB3EA33A-C2DB-42CB-93A3-8E6F5EB2DAE0
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
component quimic
@oc
name
Acid clavulanic
@ro
Clavulaanzuur
@nl
Clavulansäure
@de
Klavulaanihappo
@fi
Klavulanska kiselina
@sh
Klavulanska kiselina
@sr
Klavulanska kiselina
@sr-el
Klavulanska kislina
@sl
Klavulansyra
@sv
Klavulánsav
@hu
type
label
Acid clavulanic
@ro
Clavulaanzuur
@nl
Clavulansäure
@de
Klavulaanihappo
@fi
Klavulanska kiselina
@sh
Klavulanska kiselina
@sr
Klavulanska kiselina
@sr-el
Klavulanska kislina
@sl
Klavulansyra
@sv
Klavulánsav
@hu
altLabel
(2R,3Z,5R)-3-(2-HYDROXYETHYLID ...... .2.0]heptane-2-carboxylic acid
@en
(Z)-(2R,5R)-3-(2-Hydroxyethyli ...... .2.0)heptane-2-carboxylic acid
@en
58001-44-8
@fr
Acide clavulanique
@en
Acido clavulanico
@en
Acido clavulanico
@es
Acido clavulánico
@es
Acidum clavulanicum
@en
Antibiotic MM 14151
@en
Antibiotic mm 14151
@en
prefLabel
Acid clavulanic
@ro
Clavulaanzuur
@nl
Clavulansäure
@de
Klavulaanihappo
@fi
Klavulanska kiselina
@sh
Klavulanska kiselina
@sr
Klavulanska kiselina
@sr-el
Klavulanska kislina
@sl
Klavulansyra
@sv
Klavulánsav
@hu